Cost and Coverage

* Verispan Managed Care Formulary Drug Audit, spring 2008. The spring 2008 data represent an estimated 63% of all US HMO subscribers whose prescription benefits are controlled by formularies.

† "Preferred brand tier" means "tier 2." Estimate derived from the use of information under license from IMS Formulary Focus, August 2008. IMS expressly reserves all rights, including rights of copying, distribution and republication.

‡ SDI's Vector One®: Payer, for the 6 month period ending August 2008. Out-of-pocket costs is the portion of the prescription cost that the patient is required to pay. These data include patients who pay the entire cost of their prescription and those who receive coverage via private insurance, Medicaid, or Medicare. VA and mail order co-pays are not included. Lower out of pocket costs to patients do not necessarily reflect a cost savings to providers. Products that are subject of a price comparison are not known to have comparable efficacy and safety.

References: 1. Data on file, Procter & Gamble Pharmaceuticals, Inc.